weight regain tirzepatide withdrawal leads to 25% in 82.5% of adults weight gain after stopping tirzepatide

We believe the positive phase three data from the SUMMIT trial do support an indication

Alternative Names: CJC-1295: Mod GRF 1-29, Ipamorelin: NNC 26-0161 CJC-1295 & Ipamorelin Studies and Research Data Research on Gastric Function and Ipamorelin Studies indicate that Ipamorelin may contribute to gastrointestinal activity by interacting with ghrelin receptors

This is especially important for those with oily or combination skin, as harsh cleansers can trigger excess oil production as a compensatory response

Both groups received lifestyle counseling throughout, so the comparison is semaglutide plus counseling against placebo plus counseling, not against no intervention